Acadian Asset Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-8,566
| Closed | -$1.35M | – | 2320 |
|
|
2024
Q2 | $1.35M | Buy |
+8,566
| New | +$1.35M | ﹤0.01% | 894 |
|
|
2024
Q1 | – | Sell |
-1,879
| Closed | -$180K | – | 1774 |
|
|
2023
Q4 | $180K | Buy |
+1,879
| New | +$180K | ﹤0.01% | 1252 |
|
|
2023
Q3 | – | Sell |
-498
| Closed | -$57K | – | 1832 |
|
|
2023
Q2 | $57K | Sell |
498
-494
| -50% | -$56.5K | ﹤0.01% | 1509 |
|
|
2023
Q1 | $136K | Buy |
992
+100
| +11% | +$13.7K | ﹤0.01% | 1336 |
|
|
2022
Q4 | $115K | Sell |
892
-4,384
| -83% | -$565K | ﹤0.01% | 1405 |
|
|
2022
Q3 | $581K | Buy |
5,276
+2,271
| +76% | +$250K | ﹤0.01% | 951 |
|
|
2022
Q2 | $224K | Buy |
+3,005
| New | +$224K | ﹤0.01% | 1172 |
|
|
2022
Q1 | – | Sell |
-5,683
| Closed | -$510K | – | 1788 |
|
|
2021
Q4 | $510K | Sell |
5,683
-1,001
| -15% | -$89.8K | ﹤0.01% | 1006 |
|
|
2021
Q3 | $617K | Buy |
+6,684
| New | +$617K | ﹤0.01% | 983 |
|
|
2021
Q2 | – | Sell |
-3,819
| Closed | -$285K | – | 2197 |
|
|
2021
Q1 | $285K | Buy |
+3,819
| New | +$285K | ﹤0.01% | 1382 |
|
|
2020
Q3 | – | Sell |
-173
| Closed | -$28K | – | 2347 |
|
|
2020
Q2 | $28K | Buy |
+173
| New | +$28K | ﹤0.01% | 2065 |
|